Maschauer, S.; Einsiedel, J.; Reich, D.; Hübner, H.; Gmeiner, P.; Wester, H.-J.; Prante, O.; Notni, J.
Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors. Pharmaceuticals 2017, 10, 29.
https://doi.org/10.3390/ph10010029
AMA Style
Maschauer S, Einsiedel J, Reich D, Hübner H, Gmeiner P, Wester H-J, Prante O, Notni J.
Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors. Pharmaceuticals. 2017; 10(1):29.
https://doi.org/10.3390/ph10010029
Chicago/Turabian Style
Maschauer, Simone, Jürgen Einsiedel, Dominik Reich, Harald Hübner, Peter Gmeiner, Hans-Jürgen Wester, Olaf Prante, and Johannes Notni.
2017. "Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors" Pharmaceuticals 10, no. 1: 29.
https://doi.org/10.3390/ph10010029
APA Style
Maschauer, S., Einsiedel, J., Reich, D., Hübner, H., Gmeiner, P., Wester, H. -J., Prante, O., & Notni, J.
(2017). Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors. Pharmaceuticals, 10(1), 29.
https://doi.org/10.3390/ph10010029